Literature DB >> 3984656

Gastric cancer with special reference to prognostic factors. A review of 779 cases.

J Nielsen, J Aagaard, C Toftgaard.   

Abstract

A series of 779 patients with gastric cancer diagnosed in the 20-year period 1960-1979 is presented. Surgery was performed in 86% of the cases, but was judged to be radical in only 28%. The operative mortality in the total period was 14.3%, with a fall in the final 5-year period. Patient age, stage of cancer and radicality of operation were prognostic factors as regards survival time. The overall 5-year survival rate was 12%. The rate was 37% after radical surgery, increasing to 49% when corrected for age and sex. The survival rate was unchanged during the period of the study. The crude 5-year survival among the patients with radical surgery was 41% and was independent of the type of surgery. Median age was significantly lower in the patients with early-stage cancer than in the series as a whole. The numbers of younger patients increased during the last ten years of the study.

Entities:  

Mesh:

Year:  1985        PMID: 3984656

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  6 in total

1.  Survival in stomach cancer is improving: results of a nationwide population-based Swedish study.

Authors:  L E Hansson; P Sparén; O Nyrén
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

2.  Advanced or metastatic gastric cancer in elderly patients: clinicopathological, prognostic factors and treatments.

Authors:  Z Lu; M Lu; X Zhang; J Li; J Zhou; J Gong; J Gao; J Li; X Zhang; Y Li; L Shen
Journal:  Clin Transl Oncol       Date:  2012-10-02       Impact factor: 3.405

3.  Prognostic factors in resectable gastric cancer: results of EORTC study no. 40813 on FAM adjuvant chemotherapy.

Authors:  M Lise; D Nitti; A Marchet; T Sahmoud; N Duez; A Fornasiero; J G dos Santos; R Labianca; P Lasser; M Gignoux
Journal:  Ann Surg Oncol       Date:  1995-11       Impact factor: 5.344

4.  Perspectives of surgery and multimodality treatment in gastric carcinoma.

Authors:  H J Meyer; J Jähne; H Wilke
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

5.  Metastatic mode and DNA ploidy in gastric carcinoma.

Authors:  Y Umehara; T Kimura; M Yoshida; N Oba; Y Harada
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

6.  Serum C1-esterase inhibitor, an essential and independent prognosticator of gastric carcinoma.

Authors:  C W Janssen; R T Lie; H Maartmann-Moe; R Matre
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.